Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1
- 30 September 2003
- journal article
- research article
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 136 (3), 407-418
- https://doi.org/10.1016/s0002-9394(03)00223-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Verteporfin Therapy of Subfoveal Choroidal Neovascularization in Patients With Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 2002
- GUIDELINES FOR USING VERTEPORFIN (VISUDYNE®) IN PHOTODYNAMIC THERAPY TO TREAT CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSESRetina, 2002
- Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial—VIP report no. 1Ophthalmology, 2001
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?British Journal of Ophthalmology, 2000
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinAmerican Journal of Ophthalmology, 1999
- Laser Photocoagulation of Subfoveal Neovascular Lesions in Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 1991
- Photocoagulation for Diabetic Macular EdemaAmerican Journal of Ophthalmology, 1985